CONCORDBIO IN EQUITY
loading…—
Day range—
52-week range—
Market cap—
P/E · TTM—
As of—
| ₹ CR · FY | FY22 | FY23 | FY24 | FY25 | FY26 | Sep'26 | YOY |
|---|---|---|---|---|---|---|---|
| Profit & loss | |||||||
| Revenue | 713 | 853 | 1,017 | 1,200 | 1,055 | — | — |
| Operating profit | 270 | 344 | 432 | 506 | 368 | — | — |
| OPM % | 37.9% | 40.3% | 42.5% | 42.2% | 34.9% | — | |
| Interest | 6 | 5 | 3 | 1 | 1 | — | — |
| Profit before tax | 238 | 322 | 413 | 495 | 345 | — | — |
| Net profit | 175 | 240 | 308 | 372 | 259 | — | — |
| NPM % | 24.5% | 28.1% | 30.3% | 31.0% | 24.5% | — | |
| Balance sheet & cash | |||||||
| Total assets | 1,313 | 1,514 | 1,701 | 2,034 | 2,232 | 2,327 | +4.3% |
| Equity | 1,104 | 1,290 | 1,526 | 1,812 | 2,017 | 2,075 | +2.9% |
| Debt | 62 | 32 | 10 | 3 | 2 | 2 | 0% |
| Cash from ops | 207 | 246 | 265 | 245 | 267 | — | — |
| Capex | — | — | — | — | — | — | — |
| CHECK | RESULT | VALUE |
|---|---|---|
| Net profit positive | n/a | — |
| Operating cash flow positive | n/a | — |
| ROA improved | n/a | 11.6% → — |
| Cash from ops > net profit | n/a | — |
| Leverage fell | ✓ PASS | 0 → 0 |
| Current ratio improved | n/a | — → — |
| Gross margin improved | n/a | 34.9% → — |
| Asset turnover improved | n/a | 0.47 → — |
| Interest cover above 3× | n/a | — |
| ₹ CR · QUARTER | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 | Q2 FY27 | YOY |
|---|---|---|---|---|---|---|---|---|---|
| Profit & loss | |||||||||
| Revenue | 244 | 430 | 204 | 247 | 278 | 326 | 257 | 309 | +25.1% |
| Operating profit | 98 | 189 | 61 | 88 | 98 | 118 | 82 |
| 104 |
| +18.2% |
| OPM % | 40.2% | 44.0% | 29.9% | 35.6% | 35.3% | 36.2% | 31.9% | 33.7% |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |
| Profit before tax | 101 | 184 | 59 | 86 | 86 | 114 | 78 | 95 | +10.5% |
| Net profit | 76 | 140 | 44 | 63 | 64 | 88 | 58 | 70 | +11.1% |
| NPM % | 31.1% | 32.6% | 21.6% | 25.5% | 23.0% | 27.0% | 22.6% | 22.7% |